Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ

$560.11

-$11.33 (1.98%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$552.75$573.67

Open $571.84

52 Week Range

$265.00$605.00

Previous Close $571.44

Market Cap12.42B

Volume164.43K

Avg Volume345.11K

P/E (TTM)-44.12

EPS (TTM)$-12.69

Dividend / YieldN/A

Dividend StreakN/A

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Company Info

SectorHealthcare

IndustryBiotechnology

CEOWilliam J. Sibold

Employees528

Websitewww.madrigalpharma.com

Trading Information

Open

$571.84

Previous Close

$571.44

Day High

$573.67

Day Low

$552.75

52 Week High

$605.00

52 Week Low

$265.00